InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Brintnall John, Directeur Stratégique. Director active across 1 company, notably CVRx, Inc.. In total, 3 reports have been recorded. Activity tracked since 30 December 2021. The latest transaction was disclosed on 22 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Brintnall John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
1,590 股@ US$0.23739.5% 占其流量Common StockSEC:0001415889-22-004253:0
2,550 股@ US$0.23760.5% 占其流量Common StockSEC:0001179110-22-000007:0
2,242 股Common StockSEC:0001179110-21-007342:0
3 条申报中的 3 条
About Brintnall John
John Brintnall serves as Chief Strategy Officer and Secretary at CVRx, Inc. He is responsible for formulating and executing the company's strategy. CVRx is a medical technology company developing innovative solutions to treat hypertension. Mr. Brintnall's expertise in the healthcare sector allows him to contribute to the strategic direction of the company.
